Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis

Background: Guidelines suggest pharmacological thromboprophylaxis for patients with multiple myeloma (MM) treated with immunomodulatory drugs due to a high risk of venous thromboembolisms (VTE). Objectives: To analyze rates of VTE and bleeding, risk profiles, and patterns of thromboprophylaxis in MM...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lea Vospernik, Hermine Agis, Cihan Ay, Lina Rüsing, Heinz Gisslinger, Christina Brunbauer, Clara Sophie Michel, Ingrid Simonitsch-Klupp, Alexandra Kaider, Maria-Theresa Krauth, Julia Riedl
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-08-01
Col·lecció:	Research and Practice in Thrombosis and Haemostasis
Matèries:	Anticoagulants clinical decision rules hemorrhage multiple myeloma venous thromboembolism
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2475037925004868
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!